Mae'r cynnwys hwn ar gael yn Saesneg yn unig.
Trosolwg
Ymchil
Traethawd ymchwil
Are prostate cancer stem cells susceptible to T cell mediated killing?
Cyhoeddiadau
2021
- Hanna, S. J. et al. 2021. T cell phenotypes in COVID-19 - a living review. Oxford Open Immunology 2(1) (10.1093/oxfimm/iqaa007)
- Codd, A. S. et al. 2021. Neutrophilia, lymphopenia and myeloid dysfunction: A living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology. Oxford Open Immunology 2(1), article number: iqab016. (10.1093/oxfimm/iqab016)
2019
- Hongo, A. et al. 2019. Upstream position of proline defines peptide-HLA class I repertoire formation and CD8+ T cell responses. Journal of Immunology 202(10), pp. 2849-2855. (10.4049/jimmunol.1900029)
- Codd, A. 2019. Identification of novel antigens for T cell targeting of prostate cancer stem cells. PhD Thesis, Cardiff University.
2018
- Codd, A. S., Kanaseki, T., Torigo, T. and Tabi, Z. 2018. Cancer stem cells as targets for immunotherapy. Immunology 153(3), pp. 304-314. (10.1111/imm.12866)
2016
- Codd, A., Al-Taei, S. and Tabi, Z. 2016. Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapies. Annals of Translational Medicine 4(S1), pp. S56. (10.21037/atm.2016.10.30)